Elevated plasma levels of asymmetric dimethylarginine and the risk for arrhythmic death in ischemic and non-ischemic, dilated cardiomyopathy - a prospective, controlled long-term study.

CONCLUSIONS: Plasma levels of ADMA were elevated in patients with ICM or DCM as compared to controls, but were not significantly predictive for overall mortality or the risk for arrhythmic death. PMID: 32504703 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32504703?dopt=Abstract

Source: Clinical Biochemistry - June 2, 2020 Category: Biochemistry Authors: Leo Burger A, Stojkovic S, Diedrich A, Demyanets S, Wojta J, Pezawas T Tags: Clin Biochem Source Type: research